1. Serum Tumor Marker Carbohydrate Antigen 125 Levels and Carotid Atherosclerosis in Patients with Coronary Artery Disease
- Author
-
Cun-Ren Meng, Zhao-Xia Zhang, Guo-Yao Sang, Tian Tian, and Zhao-Yun Chen
- Subjects
0301 basic medicine ,Carotid atherosclerosis ,medicine.medical_specialty ,endocrine system diseases ,030204 cardiovascular system & hematology ,Positive correlation ,Gastroenterology ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Medicine ,In patient ,cardiovascular diseases ,Carotid intima-media thickness ,Tumor marker ,business.industry ,General Medicine ,medicine.disease ,female genital diseases and pregnancy complications ,Serum carbohydrate antigen 125 ,030104 developmental biology ,cardiovascular system ,Serum ca125 ,Multiple linear regression analysis ,business ,Carbohydrate antigen ,Regular Articles - Abstract
Objective We assessed the correlation between serum carbohydrate antigen 125 (CA125) and carotid intima-media thickness (cIMT) in patients with coronary artery disease (CAD). Methods We collected 518 CAD patients from the cardiovascular disease center in our hospital, and all cIMT values were measured in patients with CAD. Results The serum CA125 concentrations were found to be increased in CAD patients with early carotid atherosclerosis compared with patients without early carotid atherosclerosis (20.1±7.72 vs. 17.7±6.41 U/mL, p Conclusions We found that serum CA125 concentrations were positively correlated with cIMT in CAD patients, serum CA125 might be a potential biochemical marker for the estimation of atherosclerosis in patients with CAD.
- Published
- 2018